Analysts Expect Tenet Healthcare Corp (THC) Will Post Quarterly Sales of $4.89 Billion

Wall Street brokerages expect that Tenet Healthcare Corp (NYSE:THC) will report sales of $4.89 billion for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Tenet Healthcare’s earnings. The highest sales estimate is $5.00 billion and the lowest is $4.79 billion. Tenet Healthcare reported sales of $4.86 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 0.6%. The firm is expected to report its next earnings report after the market closes on Monday, February 26th.

According to Zacks, analysts expect that Tenet Healthcare will report full-year sales of $4.89 billion for the current year, with estimates ranging from $19.00 billion to $19.19 billion. For the next fiscal year, analysts anticipate that the company will post sales of $17.99 billion per share, with estimates ranging from $17.84 billion to $18.14 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Tenet Healthcare.

Several equities analysts have recently weighed in on THC shares. Jefferies Group set a $20.00 price objective on shares of Tenet Healthcare and gave the company a “buy” rating in a report on Monday, October 30th. Citigroup upgraded shares of Tenet Healthcare from a “neutral” rating to a “buy” rating in a report on Tuesday, December 12th. Leerink Swann reiterated a “buy” rating and set a $27.00 price objective on shares of Tenet Healthcare in a report on Wednesday, December 20th. Morgan Stanley dropped their price objective on shares of Tenet Healthcare from $15.00 to $14.00 and set an “equal weight” rating on the stock in a report on Thursday, November 9th. Finally, Mizuho reiterated a “hold” rating on shares of Tenet Healthcare in a report on Friday, November 10th. Five equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the stock. Tenet Healthcare has an average rating of “Hold” and an average target price of $18.36.

In related news, Director George Fredrick Smitherman sold 14,300 shares of the company’s stock in a transaction dated Tuesday, January 30th. The shares were sold at an average price of $2.02, for a total value of $28,886.00. Insiders sold a total of 54,600 shares of company stock worth $94,146 in the last 90 days. 3.10% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Flinton Capital Management LLC grew its position in Tenet Healthcare by 65.7% in the 2nd quarter. Flinton Capital Management LLC now owns 7,888 shares of the company’s stock worth $153,000 after purchasing an additional 3,128 shares in the last quarter. Pentwater Capital Management LP bought a new stake in Tenet Healthcare in the 3rd quarter worth about $164,000. Russell Investments Group Ltd. grew its position in Tenet Healthcare by 182.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 10,525 shares of the company’s stock worth $173,000 after purchasing an additional 6,800 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in Tenet Healthcare in the 3rd quarter worth about $183,000. Finally, Sterling Capital Management LLC bought a new stake in Tenet Healthcare in the 3rd quarter worth about $227,000.

Shares of Tenet Healthcare (THC) traded up $0.43 during midday trading on Friday, hitting $18.03. 2,541,340 shares of the stock traded hands, compared to its average volume of 2,310,000. Tenet Healthcare has a 52-week low of $12.25 and a 52-week high of $22.72. The firm has a market capitalization of $1,820.00, a price-to-earnings ratio of -3.28, a P/E/G ratio of 3.45 and a beta of 1.24. The company has a quick ratio of 1.21, a current ratio of 1.28 and a debt-to-equity ratio of 21.21.

ILLEGAL ACTIVITY NOTICE: “Analysts Expect Tenet Healthcare Corp (THC) Will Post Quarterly Sales of $4.89 Billion” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/10/analysts-expect-tenet-healthcare-corp-thc-will-post-quarterly-sales-of-4-89-billion.html.

About Tenet Healthcare

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Get a free copy of the Zacks research report on Tenet Healthcare (THC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply